Community-acquired acute maxillary sinusitis or rhinosinusitis in adults in France:: current management

被引:6
作者
Klossek, JM
Chidiac, C
Serrano, E
Gehanno, P
Naudé, P
Amsellem, J
Dubreuil, C
Ferrand, PA
Jankowski, R
May, T
Bébéar, C
Dubreuil, L
机构
[1] CHU Hop Jean Bernard, Serv ORL, F-86021 Poitiers, France
[2] Hop Croix Rousse, Serv Malad Infect, F-69317 Lyon 4, France
[3] Hop Larrey, Serv ORL, F-31059 Toulouse 9, France
[4] Med Generaliste, F-67000 Strasbourg, France
[5] Univ Victor Segalen Bordeaux, Bacteriol Lab, F-33076 Bordeaux, France
[6] Ctr Hosp Lyon sud, Serv ORL, F-69495 Pierre Benite, France
[7] Fac Pharm, Lab Microbiol Clin, F-59006 Lille, France
[8] Med Generaliste, F-49000 Angers, France
[9] Hop Bichat Claude Bernard, Serv ORL, F-75877 Paris 18, France
[10] Hop Cent, Serv ORL, F-54035 Nancy, France
[11] Hop Brabois, Serv Malad Infect, F-54511 Vandoeuvre Les Nancy, France
[12] Med Generaliste, F-54280 Seichamps, France
来源
PRESSE MEDICALE | 2005年 / 34卷 / 22期
关键词
D O I
10.1016/S0755-4982(05)84269-1
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Sinus infections, often viral, are a common reason for physician visits. The multiplicity of clinical presentations makes its diagnosis difficult. The problem is to recognize bacterial infection without additional testing, except in cases of treatment failures, complications or relapse. Patients with signs suggestive of rhinosinusitis fall into one of four basic clinical situations: common colds, "doubtful " rhinosinusitis, apparent acute maxillary bacterial rhinosinusitis, and complications. Anterior rhinoscopy may help confirm diagnosis. Current bacterial epidemiology is based on the results of clinical studies, microbial ecology, and samples taken in cases of treatment failure. The two bacteria isolated most frequently are Streptococcus pneumoniae and Haemophilus influenzae, both of which pose resistance problems. Moraxella catarrhalis, Streptococcus pyogenes and Staphylococcus aureus are isolated less often. The dominant issue in management of acute rhinosinusitis is whether to use antibiotic or symptomatic treatment. For viral infections, antibiotic therapy is useless and highly inadvisable. For "doubtful" infections, symptomatic treatment is likely to lead to recovery. The use of non-recommended antibiotics also increases the risk of selection of resistant bacteria. When bacterial rhinosinusitis is strongly suspected, recourse to antibiotic treatment is recommended in view of the benefits in this situation (AFSSAPS 2005). This treatment is probabilistic, should be decided at the end of the consultation, and follows the AFSSAPS guidelines.
引用
收藏
页码:1755 / 1763
页数:9
相关论文
共 28 条
[1]
AFSSAPS, 2005, ANT VOIE GEN PRAT CO
[2]
Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain -: J Antimicrob Chemother 2001; 48:145-148 [J].
Alós, JI ;
Oteo, J ;
Aracil, B ;
Gómez-Garcés, JL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (01) :145-148
[3]
Burke T F, 1994, Acad Emerg Med, V1, P235
[4]
Epidemiology of Haemophilus influenzae strains identified in 2001 in France, and assessment of their susceptibility to beta-lactams [J].
Dabernat, H ;
Seguy, A ;
Faucon, G ;
Delmas, C .
MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 (02) :97-101
[5]
In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey [J].
Decousser, JW ;
Allouch, PY ;
Courvalin, P ;
Leclercq, R .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (03) :186-195
[6]
DIAGNOSIS OF SINUSITIS IN ADULTS - HISTORY, PHYSICAL-EXAMINATION, NASAL CYTOLOGY, ECHO, AND RHINOSCOPE [J].
DRUCE, HM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (03) :436-441
[7]
Drugeon H. B., 2002, Antibiotiques, V4, P193
[8]
Epidemiology of bacterial resistance to antibiotics in the respiratory tract (France 2000-2001); assessment of telithromycin efficacy [J].
Drugeon, HB ;
Juvin, ME ;
Bensalah, A ;
Moniot-Ville, N .
MEDECINE ET MALADIES INFECTIEUSES, 2003, 33 (02) :104-109
[9]
DRUGEON HB, 2004, ANTIBIOTIQUES, V6, P1
[10]
FERRAND PA, 2000, CONCOURS MED, V122, P2974